Can-Fite BioPharma Ltd. Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
Can-Fite BioPharma Ltd. (CANF) had Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net of $386.00 thousand as of 2023-12-31, per its 20-F filed 2024-03-28.
Discontinued › Notes › Debt › Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet · last filed 2024-03-28
- 2023-12-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $386.00K.
- 2021-12-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $980.00K.
| Period end | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net |
|---|---|
| 2023-12-31 | $386.00K 20-F · filed 2024-03-28 |
| 2021-12-31 | $980.00K 20-F · filed 2024-03-28 |